Delisting risk
Processa Pharmaceuticals (PCSA)
Develops altered-metabolism cancer therapies from in-licensed cytotoxic drugs.
$2.03
Pre-market−0.06 (−2.87%)
At close$2.09(+1.95%)
Something off on this page? Send us feedback.
Next report
Oct 29, 2026
in 56 days
EPS estimate
−$1.00
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Oct '26
Reported−$18.50−$7.50−$6.25−$1.75−$18.50−$1.29−$1.19Pending
Estimate−$0.76−$19.25−$5.75−$2.00−$1.50−$1.00−$1.00−$1.00
Surprise−2,334.2%+61.0%−8.7%+12.5%−1,133.3%−29.0%−19.0%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Oct '26
Reported———————Pending
Estimate————————
Surprise————————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Oct 2026 | −$1.00 | — | — |
| Aug 2026 | −$1.00 | −$1.19 | −19.0% |
| May 2026 | −$1.00 | −$1.29 | −29.0% |
| Mar 2026 | −$1.50 | −$18.50 | −1,133.3% |
| Nov 2025 | −$2.00 | −$1.75 | +12.5% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Oct 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Apr 2018 | |||
| Nov 2017 | |||
| Oct 2017 | |||
| Sep 2017 | — | — | — |
| Sep 2017 | — | — | — |
| Aug 2017 | — | — | — |
| Aug 2017 | |||
| Jun 2017 | |||
| Dec 2015 | |||
| Aug 2015 | |||
| May 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Oct 29, 2026 | −$1.00 | — | — | — | — | — | — |
| Aug 14, 2026 | −$1.00 | −$1.19 | −19.0% | — | — | — | −2.8% |
| May 7, 2026 | −$1.00 | −$1.29 | −29.0% | — | — | — | −4.9% |
| Mar 19, 2026 | −$1.50 | −$18.50 | −1,133.3% | — | — | — | −0.4% |
| Nov 6, 2025 | −$2.00 | −$1.75 | +12.5% | — | — | — | −3.2% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||||||
| Aug 7, 2025 | |||||||
| May 8, 2025 | |||||||
| Mar 20, 2025 | |||||||
| Oct 30, 2024 | |||||||
| Aug 13, 2024 | |||||||
| May 10, 2024 | |||||||
| Mar 29, 2024 | |||||||
| Nov 13, 2023 | |||||||
| Aug 10, 2023 | |||||||
| May 15, 2023 | |||||||
| Mar 30, 2023 | |||||||
| Nov 8, 2022 | |||||||
| Aug 12, 2022 | |||||||
| May 12, 2022 | |||||||
| Mar 30, 2022 | |||||||
| Nov 12, 2021 | |||||||
| Aug 12, 2021 | |||||||
| May 13, 2021 | |||||||
| Mar 25, 2021 | |||||||
| Nov 12, 2020 | |||||||
| Aug 5, 2020 | |||||||
| May 15, 2020 | |||||||
| Mar 6, 2020 | |||||||
| Nov 14, 2019 | |||||||
| Aug 14, 2019 | |||||||
| May 14, 2019 | |||||||
| Mar 28, 2019 | |||||||
| Nov 13, 2018 | |||||||
| Aug 14, 2018 | |||||||
| May 21, 2018 | |||||||
| Apr 16, 2018 | |||||||
| Nov 20, 2017 | |||||||
| Oct 4, 2017 | |||||||
| Sep 25, 2017 | — | — | — | — | — | — | — |
| Sep 8, 2017 | — | — | — | — | — | — | — |
| Aug 30, 2017 | — | — | — | — | — | — | — |
| Aug 7, 2017 | |||||||
| Jun 19, 2017 | |||||||
| Dec 1, 2015 | |||||||
| Aug 19, 2015 | |||||||
| May 15, 2015 | |||||||